-
Antibiotic Exposure May Be Tied to Risk for Parkinson Disease
drugs
December 19, 2019
Exposure to certain types of oral antibiotics may be associated with an elevated risk for Parkinson disease (PD), according to a study published online in Movement Disorders.
-
SAE Rate Higher With Nilotinib Versus Placebo in Parkinson Disease
drugs
December 18, 2019
Among patients with moderately severe Parkinson disease, exploratory biomarkers are altered in response to nilotinib, but the rate of serious adverse events (SAEs) is significantly higher in ...
-
Cancer Drug Nilotinib Shows Promise for Parkinson's Patients
drugs
December 17, 2019
A drug used to fight chronic myeloid leukemia might also relieve symptoms of Parkinson's disease, a new study finds.
-
High-tech method for uniquely targeted gene therapy developed
worldpharmanews
December 17, 2019
Neuroscientists at Lund University in Sweden have developed a new technology that engineers the shell of a virus to deliver gene therapy to the exact cell type in the body that ...
-
Eisai, Meiji receive approval for Parkinson's drug
biospectrumasia
September 23, 2019
The most common ADRs (incidence 3% and higher) observed with patients were dyskinesia, falls, and constipation.
-
QPS Expands Global Footprint
contractpharma
September 20, 2019
QPS, a CRO, has expanded its global footprint with new clinics in the Netherlands and India. QPS Netherlands recently opening a second clinic ...
-
Kyowa Kirin gets FDA nod for Parkinson’s drug
biospectrumasia
September 04, 2019
Kyowa Kirin Announces FDA Approval of NOURIANZTM (istradefylline) for Use in Parkinson’s Disease
-
FDA approves Kyowa Kirin’s Nourianz drug for Parkinson’s disease
pharmaceutical-technology
September 03, 2019
The US Food and Drug Administration (FDA) has approved Japanese company Kyowa Kirin’s drug Nourianz (istradefylline) as an add-on to the existing drug levodopa/carbidopa to treat adults...
-
Cerebrovascular Risk Factors May Up Risk for Parkinson Disease
drugs
September 02, 2019
Most cerebrovascular risk factors are associated with an increased risk for subsequent diagnosis of Parkinson disease...
-
How Heart Health Factors May Affect Your Parkinson's Risk
drugs
September 02, 2019
People who have reduced blood flow in their brain due to medical conditions and lifestyle habits may be vulnerable to Parkinson's disease, new research suggests.